AAPL

220.64

-0.63%↓

MSFT

401.34

-1.56%↓

NVDA

102.72

-3.98%↓

TSM

157.15

-3.92%↓

ORCL

141.88

-0.39%↓

AAPL

220.64

-0.63%↓

MSFT

401.34

-1.56%↓

NVDA

102.72

-3.98%↓

TSM

157.15

-3.92%↓

ORCL

141.88

-0.39%↓

AAPL

220.64

-0.63%↓

MSFT

401.34

-1.56%↓

NVDA

102.72

-3.98%↓

TSM

157.15

-3.92%↓

ORCL

141.88

-0.39%↓

AAPL

220.64

-0.63%↓

MSFT

401.34

-1.56%↓

NVDA

102.72

-3.98%↓

TSM

157.15

-3.92%↓

ORCL

141.88

-0.39%↓

AAPL

220.64

-0.63%↓

MSFT

401.34

-1.56%↓

NVDA

102.72

-3.98%↓

TSM

157.15

-3.92%↓

ORCL

141.88

-0.39%↓

Accueil・Liste d'Actions・Infosys Ltd.

Infosys Ltd.

Fermé

Secteur Technologie

22.56 -1.57

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

22.54

Max

22.62

Chiffres clés
By Trading Economics
Revenu	-60B 959M
Ventes	-384B 4.6B
P/E Moyenne du Secteur	25.25 60.694
BPA	0.23
Marge bénéficiaire	21.008
EBITDA	-90B 1.5B

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	-7.32 downside

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	96B
Ouverture précédente	24.13
Clôture précédente	22.56

Sentiment de l'Actualité

By Acuity

50%

135 / 381 Classement par Technology

Score Technique

By Trading Central

Confiance

Bearish Evidence

22.5 / 23.32 Support & Résistance

Infosys Ltd. Graphique

Actualités Associées

18 juil. 2024, 14:37 UTC

Résultats

Principaux Mouvements du Marché

Infosys Shares Rise 8% After 1Q Revenue Beat

22 juil. 2024, 04:41 UTC

Market Talk

Infosys' FY 2025 Revenue Growth Guidance May Improve Further -- Market Talk

18 juil. 2024, 11:00 UTC

Résultats

Infosys Sees FY25 Operating Margin in 20% to 22% Range >INFY.BO.BY

18 juil. 2024, 10:59 UTC

Résultats

Infosys Sees 2025 Revenue Growth in 3% to 4% Range in Constant Currency >INFY.BO.BY

18 juil. 2024, 10:58 UTC

Résultats

Infosys 1Q Rev $4.71B >INFY.BO.BY

18 juil. 2024, 10:58 UTC

Résultats

Infosys 1Q EPS 18c >INFY.BO.BY

18 juil. 2024, 10:26 UTC

Résultats

Infosys Sees FY25 Operating Margin 20%-22% >500209.BY

18 juil. 2024, 10:25 UTC

Résultats

Infosys Expects FY25 Revenue Growth of 3%-4% in Constant Currency >500209.BY

18 juil. 2024, 10:24 UTC

Résultats

Infosys 1Q Rev $4.71B Vs. $4.62B >500209.BY

18 juil. 2024, 10:23 UTC

Résultats

Infosys 1Q Net $763M Vs. Net $724M >500209.BY

19 avr. 2024, 06:49 UTC

Market Talk

Infosys' FY 2025 Revenue Guidance of 1%-3% Appears Weak -- Market Talk

18 avr. 2024, 13:38 UTC

Résultats

Infosys Sees FY25 Revenue Growth of 1%-3% >500209.BY

18 avr. 2024, 13:37 UTC

Résultats

Infosys 4Q Net $958M >500209.BY

18 avr. 2024, 13:36 UTC

Résultats

Infosys 4Q EPS 23c >500209.BY

18 avr. 2024, 13:36 UTC

Résultats

Infosys 4Q Rev $4.56B >500209.BY

18 avr. 2024, 12:46 UTC

Résultats

Infosys Beat Earnings Estimates. Why the Stock Is Tumbling. -- Barrons.com

18 avr. 2024, 12:27 UTC

Acquisitions, Fusions, Rachats

Infosys: Acquisition Is Expected to Close During 1H of Fiscal 2025 >500209.BY

18 avr. 2024, 12:26 UTC

Acquisitions, Fusions, Rachats

Infosys To Acquire Leading Engineering R&D Services Provider, In-tech >500209.BY

18 avr. 2024, 12:26 UTC

Acquisitions, Fusions, Rachats

Infosys To Acquire Leading Engineering R&D Services Provider, In-tech >500209.BY

11 janv. 2024, 13:03 UTC

Résultats

Infosys 3Q EPS 18c >INFY.BO.BY

11 janv. 2024, 13:03 UTC

Résultats

Infosys 3Q Rev $4.66B >INFY.BO.BY

11 janv. 2024, 10:50 UTC

Résultats

Infosys Guides for FY 2024 Operating Margin of 20%-22% >500209.BY

11 janv. 2024, 10:50 UTC

Résultats

Infosys Guides for FY 2024 Revenue Growth 1.5%-2.0% in Constant Currency Terms >500209.BY

11 janv. 2024, 10:47 UTC

Résultats

Infosys 3Q Net $733M Vs. Net $800M >500209.BY

11 janv. 2024, 10:46 UTC

Résultats

Infosys 3Q Rev $4.663B Vs. $4.659B >500209.BY

13 oct. 2023, 05:36 UTC

Market Talk

Infosys's FY 2024 Revenue Guidance Cut Surprises Nomura -- Market Talk

12 oct. 2023, 12:30 UTC

Résultats

Infosys Sees FY24 Oper Margin of 20%-22% >INFY.BO.BY

12 oct. 2023, 12:29 UTC

Résultats

Infosys Sees FY24 Revenue Growth of 1.0%-2.5% in Constant Currency >INFY.BO.BY

12 oct. 2023, 12:28 UTC

Résultats

Infosys 2Q Rev $4.72B >INFY.BO.BY

12 oct. 2023, 12:28 UTC

Résultats

Infosys 2Q EPS 18c >INFY.BO.BY

Comparaison

Variation de prix

Infosys Ltd. prévision

Objectif de Prix

By TipRanks

-7.32% baisse

Prévisions sur 12 Mois

Moyen 20.89 USD -7.32%

Haut 23.3 USD

Bas 17 USD

Basé sur 7 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

7 ratings

Achat

Maintien

Vente

Basé sur 7 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

22.5 / 23.32Support & Résistance

Recent bearish events outweigh bullish events.

Bullish events outweigh bearish events.

Sentiment

By Acuity

135 / 381Classement par Technologie

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Infosys Ltd.

Infosys Limited is engaged in consulting, technology, outsourcing and next-generation services. The Company, along with its subsidiaries, provides business information technology services comprising application development and maintenance, independent validation, infrastructure management, engineering services comprising product engineering and life cycle solutions and business process management; consulting and systems integration services comprising consulting, enterprise solutions, systems integration and advanced technologies; products, business platforms and solutions to accelerate intellectual property-led innovation, including Finacle, its banking solution, and offerings in the areas of Analytics, Cloud and Digital Transformation. Its segments are Financial Services and Insurance (FSI), Manufacturing and Hi-tech (MFG & Hi-TECH), Energy & utilities, Communication and Services (ECS), Retail, Consumer packaged goods and Logistics (RCL), and Life Sciences and Healthcare (LSH).